CAVAZZANA, ILARIA
 Distribuzione geografica
Continente #
EU - Europa 4.972
NA - Nord America 4.293
AS - Asia 1.119
AF - Africa 9
SA - Sud America 9
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 2
Totale 10.408
Nazione #
US - Stati Uniti d'America 4.273
IT - Italia 3.329
CN - Cina 547
UA - Ucraina 472
DE - Germania 323
SG - Singapore 240
HK - Hong Kong 175
FR - Francia 162
FI - Finlandia 161
IE - Irlanda 161
GB - Regno Unito 154
TR - Turchia 95
RU - Federazione Russa 37
IN - India 31
SE - Svezia 30
EE - Estonia 23
CA - Canada 19
RO - Romania 18
ES - Italia 17
BE - Belgio 16
NL - Olanda 11
CH - Svizzera 10
PL - Polonia 9
VN - Vietnam 8
MK - Macedonia 7
EG - Egitto 6
LU - Lussemburgo 5
AT - Austria 4
BR - Brasile 4
EU - Europa 4
GR - Grecia 4
IL - Israele 4
CZ - Repubblica Ceca 3
ID - Indonesia 3
IR - Iran 3
LI - Liechtenstein 3
PH - Filippine 3
SI - Slovenia 3
AR - Argentina 2
AU - Australia 2
CY - Cipro 2
DK - Danimarca 2
JO - Giordania 2
LT - Lituania 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
CL - Cile 1
CO - Colombia 1
DZ - Algeria 1
FK - Isole Falkland (Malvinas) 1
JP - Giappone 1
MS - Montserrat 1
MU - Mauritius 1
NO - Norvegia 1
UG - Uganda 1
UZ - Uzbekistan 1
Totale 10.408
Città #
Fairfield 640
Woodbridge 400
Jacksonville 377
Ashburn 328
Houston 292
Seattle 252
Cambridge 235
Wilmington 216
Milan 209
Princeton 189
Singapore 187
Ann Arbor 186
Hong Kong 174
Chandler 164
Rome 163
Beijing 129
Nanjing 122
Helsinki 118
New York 116
Dublin 99
Florence 96
Istanbul 89
Brescia 66
Trieste 54
Turin 41
Nanchang 40
Des Moines 36
Verona 36
Genoa 35
San Diego 34
Udine 34
Hebei 32
Lancaster 32
Shanghai 32
Shenyang 32
Padova 30
Tianjin 28
Bologna 27
London 25
Dearborn 24
Los Angeles 24
Pisa 24
Changsha 23
Genova 23
Munich 23
Tallinn 23
Bergamo 22
Syracuse 21
Menlo Park 20
Jinan 19
Reggio Nell'emilia 18
Brussels 16
Jiaxing 16
San Francisco 16
Torino 16
Modena 15
Redwood City 15
Trento 14
Desio 13
Mumbai 13
Naples 13
Toronto 13
Bari 11
Ferrara 11
Hangzhou 11
Venice 11
Catania 10
Cosenza 10
Kunming 10
Orange 10
Pozzuolo Del Friuli 10
Sassari 10
Washington 10
Lappeenranta 9
Ningbo 9
Palermo 9
Rho 9
Turriaco 9
Dong Ket 8
Fiumicino 8
Francenigo 8
Napoli 8
Norwalk 8
Nürnberg 8
Perugia 8
Cagliari 7
Dallas 7
Lecco 7
Manresa 7
Pune 7
Boardman 6
Bucharest 6
Cairo 6
Caserta 6
Cernobbio 6
Cervignano del Friuli 6
Duncan 6
Frankfurt am Main 6
Guangzhou 6
Montegranaro 6
Totale 6.129
Nome #
ANTICORPI ANTI-TH/TO NELLA SCLEROSI SISTEMICA (SSC): CORRELAZIONI CLINICHE E IMMUNOLOGICHE 2.134
ANTICORPI ANTI-RNA POLIMERASI III: UN MARKER DI ESORDIO PRECOCE DI SCLEROSI SISTEMICA 1.532
Anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus patients with articular involvement: a predictive marker for erosive disease? 152
Anti-RNA polymerase III antibodies as a risk marker for early Gastric Antral Vascular Ectasia (GAVE) in systemic sclerosis 143
Anti-RNA polymerase III antibodies: A marker of systemic sclerosis with rapid onset and skin thickening progression 132
Malignancies in Italian patients with systemic sclerosis positive for anti-RNA polymerase III antibodies 125
Endothelial dysfunction in early systemic lupus erythematosus patients and controls without previous cardiovascular events 122
Anti-argonaute2 (Ago2/Su) and -Ro antibodies identified by immunoprecipitation in primary anti-phospholipid syndrome (PAPS). 121
Macrophage activation syndrome in adult systemic lupus erythematosus: Report of seven adult cases from a single Italian rheumatology center 120
The clinico-serological spectrum of overlap myositis 119
C9orf72 Intermediate Alleles in Patients with Amyotrophic Lateral Sclerosis, Systemic Lupus Erythematosus, and Rheumatoid Arthritis 119
Anti-MJ/NXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositis/dermatomyositis. 118
Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative Group 118
Endothelial Dysfunction In Early Systemic Lupus Erythematosus Patients And Controls Without Previous Cardiovascular Events. 113
Autoantibodies' titre modulation by anti-BlyS treatment in systemic lupus erythematosus. 112
COVID-19 in patients with rheumatic diseases in northern Italy: a single-centre observational and case–control study 111
Endothelium and the brain in CNS lupus. 109
Aortic stiffness and left ventricular hypertrophy in rheumatoid arthritis: Comment on the article by Rudominer et al. 107
Anti-Th/To are common antinucleolar autoantibodies in Italian patients with scleroderma. 106
Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis 105
Are the autoimmune/inflammatory syndrome induced by adjuvants (ASIA) and the undifferentiated connective tissue disease (UCTD) related to each other? A case-control study of environmental exposures 104
The 2016 classification criteria for primary Sjogren's syndrome: What's new? 101
Renal Involvement in Primary Antiphospholipid Syndrome: Retrospective Analysis of 160 Patients. 100
METODICHE AUTOMATIZZATE PER ANTICORPI ANTINUCLEO (ANA): E' POSSIBILE SOSTITUIRE L'IMMUNOFLUORESCENZA INDIRETTA? 98
The Clinical and Histological Spectrum of Idiopathic Inflammatory Myopathies. 98
Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women 98
[Neonatal lupus: clinical features and risk of congenital cardiac heart block in newborns from mothers with anti Ro/SSA antibodies] 97
Autoantibodies and Skin Involvement in Systemic Autoimmune Diseases 95
Clinical follow-up predictors of disease pattern change in anti-Jo1 positive anti-synthetase syndrome: Results from a multicenter, international and retrospective study 92
Anti-Ro/SSA and La/SSB antibodies 92
International cohort study of 73 anti-Ku-positive patients: Association of p70/p80 anti-Ku antibodies with joint/bone features and differentiation of disease populations by using principal-components analysis 91
Primary biliary cirrhosis-related autoantibodies in a large cohort of italian patients with systemic sclerosis 90
Autoantibodies to survival of motor neuron complex in patients with polymyositis: Immunoprecipitation of D, E, F, and G proteins without other components of small nuclear ribonucleoproteins 90
Anti-topoisomerase-I antibodies in systemic lupus erythematosus and potential association with the presence of anti-dsDNA antibodies 90
Serum prealbumin is an independent predictor of mortality in systemic sclerosis outpatients 87
Update on Antiphospholipid Syndrome: Ten Topics in 2017 87
Serologic profile and mortality rates of scleroderma renal crisis in Italy 86
Evaluation of a novel particle-based assay for detection of autoantibodies in idiopathic inflammatory myopathies. 86
Complement Activation and Pregnancy Failure. 81
Rheumatoid arthritis and diabetes mellitus: Two faces of one coin? Comment on the article by Peters et al 81
Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course. 81
LUPUS ERITEMATOSO SISTEMICO AD ESORDIO TARDIVO: CARATTERISTICHE CLINICHE ED IMMUNOLOGICHE 80
Diastolic dysfunction in rheumatoid arthritis: a usual travel-mate? 77
Predictive Features and Clinical Presentation of Interstitial Lung Disease in Inflammatory Myositis 74
Intravenous cyclophosphamide for interstitial lung disease associated to systemic sclerosis: results with an 18-month long protocol including a maintenance phase 72
Complement cascade in systemic lupus erythematosus: Analyses of the three activation pathways 71
AUMENTO DELLA PROTEINA C-REATTIVA, ANTICORPI ANTI-CCP E FATTORE REUMATOIDE NELL'ARTRITE LUPICA 69
CLINICAL AND IMMUNOLOGICAL ASSOCIATION WITH AUTOANTIBODIES TO CELLULAR ANTIGEN IN A COHORT OF 532 SLE PATIENTS FROM A SINGLE CENTER 68
Analysis of C9Orf72 Expansions in Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis: Preliminary Data 68
Reference standards for the detection of anti-mitochondrial and anti-rods/rings autoantibodies 68
Una rara causa di shock cardiogeno in una giovane donna. 66
Rare Autoantibodies To Cellular Antigens In Systemic Lupus Erythematosous. 66
A prospective evaluation of endothelial dysfunction in systemic Lupus Erythematosus patients without previous cardiovascular events: preliminary results 65
Ten Year Risk of Cardiovascular Events during anti-TNF Alpha in Rheumatoid Arthritis Patients 63
Systematic Review and Meta-analysis on the Association of Occupational Exposure to Free Crystalline Silica and Rheumatoid Arthritis 62
Comparison of early and late onset systemic lupus erythematosus 62
ANTI-RNA POLYMERASE III ANTIBODIES AS A RISK MARKER FOR EARLY DEVELOPMENT OF GASTRIC ANTRAL VASCULAR ECTASIA IN SYSTEMIC SCLEROSIS 59
A prospective evaluation of endothelial dysfunction in Systemic Lupus Erythematosus patients without previous cardiovascular events: preliminary results. 59
FIRST REPORT OF ANTI-MDA5 ANTIBODIES IN A COHORT OF ITALIAN PATIENTS WITH DERMATOMYOSITIS: CLINICAL AND SEROLOGIC CORRELATIONS 58
Renal involvement in primary anti-phospholipid syndrome 57
Left ventricular function in rheumatoid arthritis during anti-TNF-α treatment: a speckle tracking prospective echocardiographic study. 57
INTERESSAMENTO RENALE NELLA SINDROME DA ANTI-FOSFOLIPIDI PRIMARIA 56
ANTICORPI ANTI-SU NELLA SINDROME DA ANTICORPI ANTI-FOSFOLIPIDI PRIMARIA (PAPS) 56
CONNETTIVITE INDIFFERENZIATA (UCTD) DI RECENTE DIAGNOSI: PROFILO CLINICO ED IMMUNOLOGICO 56
[TNF-alpha inhibition in anti-Ro/SSA positive patients with rheumatoid arthritis: clinical and immunologic effects] 56
Anti-carbamylated protein antibodies as a clinical response predictor in rheumatoid arthritis patients treated with abatacept 56
DETECTION OF ANTI-ARGONAUTE2 (AGO2/SU) AND -RO ANTIBODIES BY IMMUNOPRECIPITATION, IN PRIMARY ANTI-PHOSPHOLIPID SYNDROME (PAPS) PATIENTS: ARE THEY PREDICTIVE FOR EVOLUTION IN SYSTEMIC LUPUS ERYTHEMATOSUS? 54
Anti-Ku antibodies in connective tissue diseases: clinical and serological evaluation of 14 patients 53
Antibodies against antigens related to Scleroderma in a cohort of patients with Morphea 51
Absent or suboptimal response to booster dose of COVID-19 vaccine in patients with autoimmune systemic diseases 48
LEFT VENTRICULAR FUNCTION IN RHEUMATOID ARTHRITIS DURING ANTI-TNF ALPHA TREATMENT: PROSPECTIVE STUDY 45
Left ventricular sistolic and diastolic function in rheumatoid arthritis. 44
Left ventricular Systolic and diastolic function in rheumatoid arthritis 43
Left ventricular sistoli and diastolic function in outpatients affetected by rheumatoid arthritis 43
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments 42
STUDIO ECOCARDIOGRAFICO IN PAZIENTI AFFETTI DA ARTRITE REUMATOIDE 41
Studio ecocardiografico in pazienti affetti da artrite reumatoide. 41
The IMMENSE Study: The Interplay Between iMMune and ENdothelial Cells in Mediating Cardiovascular Risk in Systemic Lupus Erythematosus 41
Systematic review and meta-analysis of epidemiological studies on the association of occupational exposure to free crystalline silica and systemic lupus erythematosus 40
Timing of onset affects arthritis presentation pattern in antisyntethase syndrome 40
The clinical phenotype of Systemic Sclerosis patients with anti-PM/Scl antibodies: results from the EUSTAR cohort 38
Early echocardiographic alterations in SSc with anti-RNA polymerase III antibodies 37
Hepatitis C virus infection and primary Sjögren's Syndrome: A clinical and serologic description of 9 patients 37
Idiopathic inflammatory myopathies: Narrative review of unmet needs in clinical practice guidelines 36
Reply to: Anti-carbamylated protein antibodies are associated with early abatacept response in rheumatoid arthritis by Castellanos-Moreira et al 34
Real life picture of the use of intravenous immunoglobulins in idiopathic inflammatory myopathies: Results of a multicentric study 30
Serum IgG2 antibody multicomposition in systemic lupus erythematosus and lupus nephritis (Part 1): cross-sectional analysis 30
Second Wave Antibodies in Autoimmune Renal Diseases: The Case of Lupus Nephritis 30
An Italian Multicenter Study on Anti-NXP2 Antibodies: Clinical and Serological Associations 29
Ventricular-arterial coupling in systemic lupus erythematosus women without cardiovascular risk factors 24
Endothelial Dysfunction in Systemic Lupus Erythematosus and Systemic Sclerosis: A Common Trigger for Different Microvascular Diseases 23
Stopping bDMARDs at the beginning of pregnancy is associated with disease flares and preterm delivery in women with rheumatoid arthritis 22
Calprotectin as a biomarker in rheumatoid arthritis: the potential predictive value of response to treatment 21
Anti-Th/To antibodies in systemic sclerosis: analysis of long-term follow-up of pulmonary involvement, organ damage accrual and mortality in an Italian cohort with a case-control study 20
Efficacy of COVID-19 mRNA vaccination in patients with autoimmune disorders: humoral and cellular immune response 20
Geographical heterogeneity of clinical and serological phenotypes of systemic sclerosis observed at tertiary referral centres. The experience of the Italian SIR-SPRING registry and review of the world literature 19
Systemic sclerosis sine scleroderma: clinical and serological features and relationship with other cutaneous subsets in a large series of patients from the national registry 'SPRING' of the Italian Society for Rheumatology 17
Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients' subgroups 17
Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies 17
Evaluation of the incidence of melanoma and non-melanoma skin cancer in patients with systemic lupus erythematosus and systemic sclerosis 16
Totale 10.487
Categoria #
all - tutte 44.861
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.861


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.416 0 0 0 0 143 224 201 221 169 250 80 128
2020/20211.726 47 162 96 164 137 183 96 167 197 185 185 107
2021/20221.536 81 185 102 73 113 115 137 109 113 138 141 229
2022/20231.122 142 25 42 40 82 213 36 121 209 47 92 73
2023/20241.176 63 45 99 94 73 210 73 59 210 52 56 142
2024/2025702 61 73 56 280 232 0 0 0 0 0 0 0
Totale 10.563